Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

DOI10.1111/J.0006-341X.2004.00239.XzbMATH Open1274.62705OpenAlexW2049576630WikidataQ45192037 ScholiaQ45192037MaRDI QIDQ3445321FDOQ3445321

Authors Ariel Alonso, Helena Geys, Geert Molenberghs, Michael G. Kenward, Tony Vangeneugden

Publication date 11 June 2007

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1111/j.0006-341x.2004.00239.x

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
• The evaluation of surrogate endpoints.
• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• The Evaluation of Multiple Surrogate Endpoints
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments

Cites work

• General class of covariance structures for two or more repeated factors in longitudinal data analysis
• Simplified hierarchical linear models for the evaluation of surrogate endpoints
• The Analysis of Designed Experiments and Longitudinal Data by Using Smoothing Splines
• The validation of surrogate endpoints in meta-analyses of randomized experiments
• Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points

Cited in

(14)

• Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
• Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling
• A family of tests to detect misspecifications in the random-effects structure of generalized linear mixed models
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
• Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
• Fast, closed-form, and efficient estimators for hierarchical models with AR(1) covariance and unequal cluster sizes
• Surrogate Marker Evaluation from an Information Theory Perspective
• Evaluating correlation-based metric for surrogate marker qualification within a causal correlation framework
• Center-within-trial versus trial-level evaluation of surrogate endpoints
• Testing for misspecification in generalized linear mixed models
• Reliability of a longitudinal sequence of scale ratings
• Using earlier measures in a longitudinal sequence as a potential surrogate for a later one
• Quantifying the feasibility of shortening clinical trial duration using surrogate markers
• Type I and Type II Error Under Random‐Effects Misspecification in Generalized Linear Mixed Models

This page was built for publication: Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3445321)